Mesoblast Limited (ASX:MSB)
Australia · Delayed Price · Currency is AUD 2.460
+0.050 (2.07%)
Aug 28, 2026, 4:10 PM AEST
Mesoblast Market Cap
Mesoblast has a market cap or net worth of 3.13 billion as of August 28, 2026. Its market cap has decreased by -0.57% in one year.
Market Cap
3.13B
Enterprise Value
3.16B
Revenue
173.82M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.46
ChartMarket Cap Chart
Since December 16, 2004, Mesoblast's market cap has increased from 76.57M to 3.13B, an increase of 3,987.22%. That is a compound annual growth rate of 18.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 3.13B | -10.32% |
| Dec 31, 2025 | 3.49B | -1.80% |
| Dec 31, 2024 | 3.55B | 1,029.56% |
| Dec 29, 2023 | 314.59M | -50.91% |
| Dec 30, 2022 | 640.82M | -29.87% |
| Dec 31, 2021 | 913.81M | -30.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 5.29B |
| Neuren Pharmaceuticals | 2.66B |
| PYC Therapeutics | 2.22B |
| Clarity Pharmaceuticals | 873.01M |
| Clinuvel Pharmaceuticals | 462.93M |
| Racura Oncology | 441.16M |
| Starpharma Holdings | 341.09M |
| Tetratherix | 341.02M |